3 completed. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
| Phase 1 | 1 | Completed 1 |
Follow Cenicriviroc 150 mg: new trials by email Literature Review of Cenicriviroc 150 mg trials Research Report on Cenicriviroc 150 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| PERSEUS: Preliminary Efficacy and Safety of Cenicriviroc in Adult Participants With Primary Sclerosing Cholangitis Cenicriviroc 150 mg - Primary Sclerosing Cholangitis | Phase 2 | Completed | Tobira Therapeutics, Inc. | 24 | 2016-03-14 | 2018-10-01 |
| Pharmacokinetic and Safety Study of Cenicriviroc and Acid Reducing Agents When Dosed Alone or in Combination Cenicriviroc, Omeprazole, Famotidine - Healthy | Phase 1 | Completed | Tobira Therapeutics, Inc. | 48 | 2016-01-31 | 2017-11-24 |
| ORION: Effects of Cenicriviroc on Insulin Sensitivity in Subjects With Prediabetes or Type 2 Diabetes Mellitus (T2DM) and Suspected NAFLD Cenicriviroc 150 mg, Placebo - Prediabetic State, Non-alcoholic Fatty Liver Disease | Phase 2 | Completed | Tobira Therapeutics, Inc. | 45 | 2015-07-17 | 2019-10-11 |
Cholangitis, Sclerosing (1) · Diabetes Mellitus, Type 2 (1) · Non-alcoholic Fatty Liver Disease (1) · Prediabetic State (1)
United States (3) · Canada (1) · Puerto Rico (1)
Eric Lefebvre, MD (1) · J.P. Nicandro (1) · Star Seyedkazemi, PharmD (1)